Haemonetics
275 hedge funds and large institutions have $6.28B invested in Haemonetics in 2019 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 89 increasing their positions, 97 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 97
1.62% less ownership
Funds ownership: 99.67% → 98.05% (-1.6%)
26% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $16.1M
Holders
275
Holding in Top 10
2
Calls
$11.9M
Puts
$16.1M
Top Buyers
| 1 | +$143M | |
| 2 | +$41.3M | |
| 3 | +$18M | |
| 4 |
JP Morgan Chase
New York
|
+$16.7M |
| 5 |
Millennium Management
New York
|
+$13.7M |
Top Sellers
| 1 | -$73.4M | |
| 2 | -$47M | |
| 3 | -$43.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$40.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.2M |